Ascentage Pharma (AAPG) CEO Dajun Yang adds RSU shares and option grants in Form 4
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
ASCENTAGE PHARMA GROUP INTERNATIONAL Chairman and CEO Dajun Yang reported a series of equity compensation events, primarily vesting and grants of restricted stock units (RSUs) and options, with no open-market buying or selling.
On May 21, 2026, RSUs vested and were exercised into 92,746 ordinary shares held indirectly through his spouse and 95,575 ordinary shares held directly, increasing his reported ordinary share holdings to 405,280 indirectly and 1,193,569 directly. On May 20, 2026, Yang and his spouse received multiple new RSU and option awards at a $0.00 grant price, including a direct option grant over 298,194 ordinary shares and several indirect grants to his spouse, all scheduled to vest in installments between 2026 and 2030. Additional large indirect holdings are reported in entities such as the Dajun Yang Dynasty Trust and HealthQuest Pharma Limited, with Yang disclaiming beneficial ownership except to the extent of his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
188,321 shares exercised/converted
Mixed
14 txns
Insider
Yang Dajun
Role
Chairman and CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted stock units | 95,575 | $0.00 | -- |
| Exercise | Restricted stock units | 92,746 | $0.00 | -- |
| Exercise | Ordinary Shares | 95,575 | $0.00 | -- |
| Exercise | Ordinary Shares | 92,746 | $0.00 | -- |
| Grant/Award | Restricted stock units | 95,575 | $0.00 | -- |
| Grant/Award | Restricted stock units | 298,195 | $0.00 | -- |
| Grant/Award | Options | 298,194 | $0.00 | -- |
| Grant/Award | Restricted stock units | 103,365 | $0.00 | -- |
| Grant/Award | Restricted stock units | 214,999 | $0.00 | -- |
| Grant/Award | Options | 214,988 | $0.00 | -- |
| Grant/Award | Options | 103,364 | $0.00 | -- |
| Grant/Award | Restricted stock units | 92,746 | $0.00 | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Restricted stock units — 0 shares (Direct, null);
Restricted stock units — 0 shares (Indirect, By Spouse);
Ordinary Shares — 1,193,569 shares (Direct, null);
Ordinary Shares — 405,280 shares (Indirect, See Footnote (2));
Options — 298,194 shares (Direct, null);
Options — 214,988 shares (Indirect, By Spouse)
Footnotes (1)
- Shares held by Dajun Yang Dynasty Trust, of which the Reporting Person is the investment advisor. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Shares held by Reporting Person's spouse. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Shares held by HealthQuest Pharma Limited, an entity controlled by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Each restricted stock unit (the "RSUs") represent a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vested on 05/21/2026 and had no expiration date. Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person on 05/20/2026. The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date. The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and expire ten years from the date of grant. The RSUs vest in four equal increments on November 26, 2026, 2027, 2028 and 2029 and have no expiration date. The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on November 26, 2026, 2027, 2028 and 2029 and expire ten years from the date of grant. The RSUs vested on 05/21/2026 and had no expiration date. Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person's spouse on 05/20/2026.
Key Figures
RSUs exercised (indirect): 92,746 shares
RSUs exercised (direct): 95,575 shares
Direct ordinary shares after transactions: 1,193,569 shares
+5 more
8 metrics
RSUs exercised (indirect)
92,746 shares
RSUs vested to spouse-held ordinary shares on May 21, 2026
RSUs exercised (direct)
95,575 shares
RSUs vested to directly held ordinary shares on May 21, 2026
Direct ordinary shares after transactions
1,193,569 shares
Post-transaction direct holdings of ordinary shares
Indirect ordinary shares via spouse after vesting
405,280 shares
Post-transaction indirect ordinary shares held through spouse
Options granted (direct)
298,194 options
Options over ordinary shares granted on May 20, 2026 at $6.58
Options granted (indirect, spouse)
214,988 options
Spouse-held options over ordinary shares at $6.58 grant price
Additional options granted (indirect, spouse)
103,364 options
Spouse-held options over ordinary shares at $8.12 grant price
Total derivative exercises
188,321 shares
Aggregate shares from derivative exercises reported in transaction summary
Key Terms
restricted stock units, pecuniary interest, beneficial ownership, Section 16, +2 more
6 terms
restricted stock units financial
"Each restricted stock unit (the "RSUs") represent a contingent right to receive one Ordinary Share..."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
pecuniary interest financial
"The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein..."
beneficial ownership financial
"shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16..."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Section 16 regulatory
"for purposes of Section 16 or for any other purposes."
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
exercise price financial
"The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD..."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What insider transactions did AAPG Chairman Dajun Yang report on this Form 4?
Yang reported equity compensation activity, including RSU vesting into ordinary shares and new grants of RSUs and options. All transactions were coded as acquisitions or exercises, with no open-market purchases or sales disclosed in this filing.
Which new equity awards were granted to AAPG’s Dajun Yang and his spouse on May 20, 2026?
On May 20, 2026, the filing shows multiple RSU and option grants, including a direct option over 298,194 ordinary shares and several RSU and option grants held indirectly by his spouse. These awards generally vest in equal installments between 2026 and 2030.
How are Yang’s indirect holdings in AAPG structured according to the Form 4 footnotes?
Indirect holdings include shares in the Dajun Yang Dynasty Trust and HealthQuest Pharma Limited, plus spouse-held shares. Footnotes state Yang is investment advisor or spouse-related and disclaims beneficial ownership except for his pecuniary interest in these securities.
Do the AAPG Form 4 transactions involve any Rule 10b5-1 trading plans?
The disclosed footnotes describe trust, spouse and entity holdings, vesting schedules, and option terms, but provide no reference to Rule 10b5-1 trading plans. The reported events appear to be grants and vesting rather than trades under a pre-arranged selling program.